Plegridy is a medicine used to treat multiple sclerosis (MS), a disease in which inflammation damages the protective insulation around nerves (demyelination) as well as the nerves themselves. It is used specifically in adults with a type of MS known as relapsing-remitting MS, where the patient has flare-ups of symptoms (relapses) between periods of recovery (remissions). Plegridy contains the active substance peginterferon beta-1a.
Therapeutic Indication
### Therapeutic indication Treatment of relapsing remitting multiple sclerosis in adult patients.
Therapeutic Area (MeSH)
ATC Code
L03AB13
ATC Item
peginterferon beta-1a
Pharmacotherapeutic Group
Immunostimulants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| peginterferon beta-1a | N/A | Peginterferon beta-1a |
EMA Name
Plegridy
Medicine Name
Plegridy
Aliases
N/A